# Generation and characterization of a Cre-inducible MAP3K1 gain-of-function model

**Authors:** Bo Xiao, Maureen Mongan, Chia-I. Ko, Yueh-Chiang Hu, Tony DeFalco, Kenneth D. Greis, Ying Xia

PMC · DOI: 10.1242/dmm.052557 · 2026-02-24

## TL;DR

This study creates a mouse model to study the effects of overactive MAP3K1, revealing its role in developmental and sexual differentiation issues.

## Contribution

The study introduces a Cre-inducible transgenic mouse model for investigating MAP3K1 gain-of-function in vivo.

## Key findings

- MAP3K1 overexpression causes developmental abnormalities like digit fusion and epidermal thickening.
- Male fetuses show impaired sexual differentiation with reduced Sertoli and germ cell populations.
- MAP3K1 activates MAPK and WNT/β-catenin pathways and interacts with cytoskeletal proteins.

## Abstract

MAP3K1 is a multifunctional signaling kinase implicated in diverse biological processes. Although its gain-of-function variants contribute to multiple human diseases, including 46,XY disorders of sex development, mechanistic studies have been limited owing to the lack of physiologically relevant in vivo models. To address this gap, we generated a Cre-inducible Map3k1TG transgenic mouse carrying V5- and TurboID-tagged Map3k1 cDNA. Upon tamoxifen-induced Cre activation, Map3k1TG;Rosa26-CreERT2 fetuses displayed tamoxifen dose-dependent lethality and developmental abnormalities, including reduced body size, digit fusion, tail shortening and epidermal thickening, demonstrating broad developmental impact of MAP3K1 overexpression. Male fetuses additionally exhibited impaired sexual differentiation, with reduced anogenital distance and decreased Sertoli and germ cell populations. Mechanistically, MAP3K1 induction activated both MAPK and WNT/β-catenin pathways, leading to β-catenin displacement from plasma membrane in keratinocytes in vitro, and in epidermal and germ cells in vivo. TurboID-based proximity labeling further revealed cytoskeletal-associated proteins as MAP3K1 interactors, consistent with biochemical and imaging evidence showing MAP3K1 colocalization with actin filaments and centrosomes. These findings establish Map3k1TG as a versatile in vivo platform for dissecting MAP3K1 gain-of-function mechanisms in development and diseases.

Summary: Using an inducible Map3k1TG mouse model, we show that MAP3K1 colocalizes to F-actin and centrosomes and that its overexpression hyperactivates MAPK and WNT signaling, causing broad developmental and sexual differentiation defects.

## Linked entities

- **Genes:** MAP3K1 (mitogen-activated protein kinase kinase kinase 1) [NCBI Gene 4214]
- **Proteins:** MAP3K1 (mitogen-activated protein kinase kinase kinase 1), ctnnb1.S (catenin beta 1 S homeolog), ACTIN (hypothetical protein)
- **Chemicals:** tamoxifen (PubChem CID 2733526)
- **Diseases:** 46,XY disorders of sex development (MONDO:0020040)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, MAP3K1 (mitogen-activated protein kinase kinase kinase 1) [NCBI Gene 4214] {aka MAPKKK1, MEKK, MEKK 1, MEKK1, SRXY6}
- **Diseases:** DSDs (MESH:D012734), developmental abnormalities (MESH:D006130), 46,XY disorders of sex development (MESH:D058490)
- **Chemicals:** tamoxifen (MESH:D013629)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964353/full.md

---
Source: https://tomesphere.com/paper/PMC12964353